The study by Bahrani et al has reported that the adverse outcomes in stable epilepsy patients managed by telephonic review was comparable to those managed by conventional clinic management [1] . These research findings have significant public health policy implications since telephonic management enables patients to save time and money while also reducing the burden on the healthcare systems especially in resource-constrained settings. However, there exists a methodological concern which may be addressed by the authors.
The low incidence of breakthrough seizures among the patients shows good adherence to anti-epileptic drugs (AED) in them. It is clear that to maintain good medication adherence, an assured and uninterrupted supply of drugs is required by patients. A major incentive for patients from lower socioeconomic classes attending special OPD clinics for management of chronic disorders at government hospitals in India is acquisition of medication which is supplied free of cost in such facilities. However, due to limited resources, most Delhi government health facilities dispense medication refills for chronic diseases which last for 2 to 4 weeks. The authors in their methodology should therefore have specified as to what is the current practice with regard to dispensation of AED at their selected health facility and how assured AED stocks were maintained among the patients. Since the patients in the telephone review group were expected to follow up at the clinic every 3 months, ensuring AED stocks in the study subjects during the intervening period may require the health facility to dispense AED to the patient for the same duration. This poses a major barrier to scaling up the intervention in several government health facilities in India which dispense AED for a shorter duration.
The alternative, in absence of stock refill from the health facility, requires a majority of the patients to procure the prescribed AED through out of pocket (OOP) expenses since health insurance is available with less than one-fifth of the Indian population [2] . However, in that case the net cost benefit in the telephonically managed patients will be lowered since the savings made by reduction of travel and wage losses will need adjustment against the OOP expenses incurred for obtaining AED refills. The OOP expenses for acquiring AED can be quite significant since there exists significant price variation among different brands of the same oral antiepileptic drug in India [3] . Furthermore, to give a best case hypothetical example; Levetiracetam is one of the most commonly used AED in India [4] . A single generic 500 mg Levetiracetam tablet costs Rs. 5.00 as per the department of Pharmaceuticals, Government of India initiative for improving affordability of medications [5] . A stable epilepsy patient requiring 2000 mg Levetiracetam daily would then need to spend Rs. 600 a month or Rs. 1800 for 3 months. This shows that the cost incurred in OOP purchase for even a single AED from a highly subsidized pharmacy can potentially eliminate all monetary savings made by reducing frequency of clinic visits in stable epilepsy patients through telephonic management. Uniform AED access in stable epilepsy patients should therefore be ensured prior to initiating interventions which seek to reduce conventional clinic management through telephonic or other means of telecommunication.
